Picture of Sigilon Therapeutics logo

SGTX — Sigilon Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Sigilon Therapeutics Reports Second Quarter 2021 Financial Results

Aug 10 (Reuters) - Sigilon Therapeutics Inc  SGTX.O :
    * SIGILON THERAPEUTICS REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
    * SIGILON THERAPEUTICS, INC. - CASH WAS $162.4 MILLION AS OF
JUNE
30, 2021 COMPARED TO $202.2 MILLION AS OF DECEMBER 31, 2020
    * SIGILON THERAPEUTICS, INC. - QTRLY NET LOSS PER SHARE
$0.65

Source text for Eikon:  ID:nGNX1h9n9m 
Further company coverage:  SGTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sigilon Therapeutics

See all news